• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Kawashima Shusuke  川島 秀介

ORCIDConnect your ORCID iD *help
… Alternative Names

川島 秀介  カワシマ シュウスケ

Less
Researcher Number 70916436
Other IDs
Affiliation (Current) 2025: 千葉大学, 大学院医学研究院, 助教
Affiliation (based on the past Project Information) *help 2025: 千葉大学, 大学院医学研究院, 助教
2023: 千葉大学, 大学院医学研究院, 助教
Review Section/Research Field
Principal Investigator
Basic Section 53050:Dermatology-related
Keywords
Principal Investigator
IFN-g / 悪性黒色腫 / Nf-kB / MHC class I / JAK / IFN-γ / 抗腫瘍免疫応答 / 免疫チェックポイント阻害薬
  • Research Projects

    (2 results)
  • Research Products

    (2 results)
  • Co-Researchers

    (1 People)
  •  免疫関連有害事象を予防する超選択的免疫チェックポイント阻害療法の開発Principal Investigator

    • Principal Investigator
      川島 秀介
    • Project Period (FY)
      2025 – 2026
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 53050:Dermatology-related
    • Research Institution
      Chiba University
  •  IFN-gシグナル非依存的ながん免疫療法の感受性及び耐性機序の解明Principal Investigator

    • Principal Investigator
      川島 秀介
    • Project Period (FY)
      2023 – 2024
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 53050:Dermatology-related
    • Research Institution
      Chiba University

All 2023

All Journal Article Presentation

  • [Journal Article] High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNγ Signaling Pathway Defects2023

    • Author(s)
      Kawase K、Kawashima S、Nagasaki J、Inozume T、Tanji E、Kawazu M、Hanazawa T、Togashi Y
    • Journal Title

      Cancer Immunology Research

      Volume: In press Issue: 7 Pages: 895-908

    • DOI

      10.1158/2326-6066.cir-22-0815

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20H03694, KAKENHI-PROJECT-23K15261, KAKENHI-PROJECT-22K08424, KAKENHI-PROJECT-21K09625, KAKENHI-PROJECT-22K19459, KAKENHI-PROJECT-22K20824, KAKENHI-PROJECT-21H02772
  • [Presentation] High major histocompatibility complex class I expression overcomes cancer immunotherapy resistance due to interferon gamma signaling pathway defects2023

    • Author(s)
      Kawase K, Kawashima S, Nagasaki J, Inozume T, Yamamoto H, Kawazu M, Hanazawa T, Togashi Y. (2023)
    • Organizer
      AACR ANNUAL MEETING 2023
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-23K15261
  • 1.  冨樫 庸介
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi